Pre-order Enquiry
Request Free Sample
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17694257 | Publishing Date : 16-Mar-2021 | No. of pages : 127
Detailed TOC of Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transversion
1.2.3 Transition
1.3 Market by Application
1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics
1.3.3 Animal
1.3.4 Plant
1.3.5 Research
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Perspective (2016-2027)
2.2 Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Regions
2.2.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Share by Regions (2016-2021)
2.2.3 Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Regions (2022-2027)
2.3 Single Nucleotide Polymorphism (SNP) Genotyping Industry Dynamic
2.3.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Trends
2.3.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
2.3.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
2.3.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue
3.1.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (2016-2021)
3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2016-2021)
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue
3.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio
3.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2020
3.5 Single Nucleotide Polymorphism (SNP) Genotyping Key Players Head office and Area Served
3.6 Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
3.7 Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Type
4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Type (2016-2021)
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2022-2027)
5 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Application
5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Application (2016-2021)
5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
6.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
6.2.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
6.2.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
6.2.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
6.3.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
6.3.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
6.3.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
6.4.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021)
6.4.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
7.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
7.2.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
7.2.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
7.2.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
7.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
7.3.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
7.3.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
7.3.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
7.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
7.4.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021)
7.4.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
8.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
8.2.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
8.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
8.3.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
8.4 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
8.4.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
9.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
9.2.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
9.2.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
9.2.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
9.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
9.3.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
9.3.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
9.3.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
9.4 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
9.4.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021)
9.4.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
10.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
10.2.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
10.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
10.3.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
10.4 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
10.4.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.1.4 Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Details
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.2.4 Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.2.5 Affymetrix Recent Development
11.3 Applied Biosystems
11.3.1 Applied Biosystems Company Details
11.3.2 Applied Biosystems Business Overview
11.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.3.4 Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.3.5 Applied Biosystems Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.4.4 Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.5.4 Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.5.5 Beckman Coulter Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.6.4 Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.7.4 Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.7.5 Qiagen Recent Development
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Details
11.8.2 Luminex Corporation Business Overview
11.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.8.4 Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.8.5 Luminex Corporation Recent Development
11.9 Enzo Life Sciences
11.9.1 Enzo Life Sciences Company Details
11.9.2 Enzo Life Sciences Business Overview
11.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.9.4 Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.9.5 Enzo Life Sciences Recent Development
11.10 Bio-rad
11.10.1 Bio-rad Company Details
11.10.2 Bio-rad Business Overview
11.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.10.4 Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.10.5 Bio-rad Recent Development
11.11 Sequenom
11.11.1 Sequenom Company Details
11.11.2 Sequenom Business Overview
11.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.11.4 Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.11.5 Sequenom Recent Development
11.12 Ocimum Biosolutions
11.12.1 Ocimum Biosolutions Company Details
11.12.2 Ocimum Biosolutions Business Overview
11.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.12.4 Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.12.5 Ocimum Biosolutions Recent Development
11.13 GE Healthcare
11.13.1 GE Healthcare Company Details
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.13.4 GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.13.5 GE Healthcare Recent Development
11.14 GenScript
11.14.1 GenScript Company Details
11.14.2 GenScript Business Overview
11.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.14.4 GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.14.5 GenScript Recent Development
11.15 Douglas Scientific
11.15.1 Douglas Scientific Company Details
11.15.2 Douglas Scientific Business Overview
11.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.15.4 Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.15.5 Douglas Scientific Recent Development
11.16 BGI
11.16.1 BGI Company Details
11.16.2 BGI Business Overview
11.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.16.4 BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.16.5 BGI Recent Development
11.17 Beijing Sunbiotech
11.17.1 Beijing Sunbiotech Company Details
11.17.2 Beijing Sunbiotech Business Overview
11.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.17.4 Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.17.5 Beijing Sunbiotech Recent Development
11.18 HuaGene Biotech
11.18.1 HuaGene Biotech Company Details
11.18.2 HuaGene Biotech Business Overview
11.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.18.4 HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.18.5 HuaGene Biotech Recent Development
11.18 Generay Biotech
.1 Generay Biotech Company Details
.2 Generay Biotech Business Overview
.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
.4 Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
.5 Generay Biotech Recent Development
11.20 Benegene
11.20.1 Benegene Company Details
11.20.2 Benegene Business Overview
11.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.20.4 Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.20.5 Benegene Recent Development
11.21 Shanghai Biochip
11.21.1 Shanghai Biochip Company Details
11.21.2 Shanghai Biochip Business Overview
11.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.21.4 Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.21.5 Shanghai Biochip Recent Development
11.22 GENESKY
11.22.1 GENESKY Company Details
11.22.2 GENESKY Business Overview
11.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.22.4 GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.22.5 GENESKY Recent Development
11.23 HD Biosciences
11.23.1 HD Biosciences Company Details
11.23.2 HD Biosciences Business Overview
11.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.23.4 HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.23.5 HD Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transversion
Table 3. Key Players of Transition
Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2016-2021)
Table 8. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2022-2027)
Table 10. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends
Table 11. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
Table 12. Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
Table 13. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players (2016-2021)
Table 16. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2020)
Table 17. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
Table 21. Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2016-2021)
Table 25. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2016-2021)
Table 29. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027) & (US$ Million)
Table 61. Illumina Company Details
Table 62. Illumina Business Overview
Table 63. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 64. Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 65. Illumina Recent Development
Table 66. Affymetrix Company Details
Table 67. Affymetrix Business Overview
Table 68. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 69. Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 70. Affymetrix Recent Development
Table 71. Applied Biosystems Company Details
Table 72. Applied Biosystems Business Overview
Table 73. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 74. Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 75. Applied Biosystems Recent Development
Table 76. Agilent Technologies Company Details
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 79. Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 80. Agilent Technologies Recent Development
Table 81. Beckman Coulter Company Details
Table 82. Beckman Coulter Business Overview
Table 83. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 84. Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 85. Beckman Coulter Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 89. Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 94. Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 95. Qiagen Recent Development
Table 96. Luminex Corporation Company Details
Table 97. Luminex Corporation Business Overview
Table 98. Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 99. Luminex Corporation Recent Development
Table 100. Enzo Life Sciences Company Details
Table 101. Enzo Life Sciences Business Overview
Table 102. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 103. Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 104. Enzo Life Sciences Recent Development
Table 105. Bio-rad Company Details
Table 106. Bio-rad Business Overview
Table 107. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 108. Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 109. Bio-rad Recent Development
Table 110. Sequenom Company Details
Table 111. Sequenom Business Overview
Table 112. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 113. Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 114. Sequenom Recent Development
Table 115. Ocimum Biosolutions Company Details
Table 116. Ocimum Biosolutions Business Overview
Table 117. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 118. Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 119. Ocimum Biosolutions Recent Development
Table 120. GE Healthcare Company Details
Table 121. GE Healthcare Business Overview
Table 122. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 123. GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 124. GE Healthcare Recent Development
Table 125. GenScript Company Details
Table 126. GenScript Business Overview
Table 127. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 128. GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 129. GenScript Recent Development
Table 130. Douglas Scientific Company Details
Table 131. Douglas Scientific Business Overview
Table 132. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 133. Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 134. Douglas Scientific Recent Development
Table 135. BGI Company Details
Table 136. BGI Business Overview
Table 137. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 138. BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 139. BGI Recent Development
Table 140. Beijing Sunbiotech Company Details
Table 141. Beijing Sunbiotech Business Overview
Table 142. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 143. Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 144. Beijing Sunbiotech Recent Development
Table 145. HuaGene Biotech Company Details
Table 146. HuaGene Biotech Business Overview
Table 147. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 148. HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 149. HuaGene Biotech Recent Development
Table 150. Generay Biotech Company Details
Table 151. Generay Biotech Business Overview
Table 152. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 153. Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 154. Generay Biotech Recent Development
Table 155. Benegene Company Details
Table 156. Benegene Business Overview
Table 157. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 158. Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 159. Benegene Recent Development
Table 160. Shanghai Biochip Company Details
Table 161. Shanghai Biochip Business Overview
Table 162. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 163. Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 164. Shanghai Biochip Recent Development
Table 165. GENESKY Company Details
Table 166. GENESKY Business Overview
Table 167. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 168. GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 169. GENESKY Recent Development
Table 170. HD Biosciences Company Details
Table 171. HD Biosciences Business Overview
Table 172. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 173. HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 174. HD Biosciences Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type: 2020 VS 2027
Figure 2. Transversion Features
Figure 3. Transition Features
Figure 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2020 VS 2027
Figure 5. Diagnostics Case Studies
Figure 6. Animal Case Studies
Figure 7. Plant Case Studies
Figure 8. Research Case Studies
Figure 9. Others Case Studies
Figure 10. Single Nucleotide Polymorphism (SNP) Genotyping Report Years Considered
Figure 11. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions: 2020 VS 2027
Figure 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2022-2027)
Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players in 2020
Figure 16. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2020
Figure 18. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2016-2021)
Figure 19. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2022-2027)
Figure 20. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2016-2027)
Figure 22. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2016-2027)
Figure 23. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2016-2027)
Figure 24. United States Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2016-2027)
Figure 28. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2016-2027)
Figure 29. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2016-2027)
Figure 30. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2016-2027)
Figure 40. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2016-2027)
Figure 48. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2016-2027)
Figure 49. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2016-2027)
Figure 50. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2016-2027)
Figure 56. Turkey Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Illumina Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 60. Affymetrix Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 61. Applied Biosystems Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 62. Agilent Technologies Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 63. Beckman Coulter Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 65. Qiagen Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 66. Luminex Corporation Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 67. Enzo Life Sciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 68. Bio-rad Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 69. Sequenom Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 70. Ocimum Biosolutions Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 71. GE Healthcare Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 72. GenScript Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 73. Douglas Scientific Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 74. BGI Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 75. Beijing Sunbiotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 76. HuaGene Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 77. Generay Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 78. Benegene Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 79. Shanghai Biochip Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 80. GENESKY Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 81. HD Biosciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
Request Sample
Request Discount
